SCHEMBL6012779

SCHEMBL6012779

c1ccc(CCN2CCNCC23CCNCC3)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 3/20 0.49
TSHR P16473 2/20 0.43
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
ALDH1A1 P00352 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
HIF1A Q16665 1/20 0.43
HTR3A P46098 1/20 0.42
SLC6A4 P31645 3/20 0.41
SLC6A3 Q01959 3/20 0.41
SLC6A2 P23975 2/20 0.41
CYP2D6 P10635 3/20 0.40
HTR2A P28223 1/20 0.40
LMNA P02545 1/20 0.40
CHRM2 P08172 1/20 0.40
ADRA2A P08913 1/20 0.40
DRD1 P21728 1/20 0.40
MAPT P10636 1/20 0.39
OPRM1 P35372 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL7474058 0.92 KMT2A (0.46) SIGMAR1TSHRKMT2AMEN1ALDH1A1
SCHEMBL6012336 0.92 SIGMAR1 (0.57) SIGMAR1TSHRKMT2AMEN1ALDH1A1
SCHEMBL6013004 0.90 SIGMAR1 (0.52) SIGMAR1TSHRKMT2AMEN1ALDH1A1
SCHEMBL6012341 0.89 SIGMAR1 (0.51) SIGMAR1TSHRKMT2AMEN1ALDH1A1
SCHEMBL6012912 0.89 SIGMAR1 (0.51) SIGMAR1TSHRKMT2AMEN1ALDH1A1
SCHEMBL6012435 0.85 SIGMAR1 (0.53) SIGMAR1TSHRKMT2AMEN1ALDH1A1
SCHEMBL1077100 0.78 SIGMAR1 (0.51) SIGMAR1TSHRKMT2AMEN1ALDH1A1
SCHEMBL21538553 0.77 MEN1 (0.50) SIGMAR1TSHRKMT2AMEN1ALDH1A1
SCHEMBL323955 0.75 SIGMAR1 (0.56) SIGMAR1TSHRKMT2AMEN1ALDH1A1
SCHEMBL1556809 0.75 CYP2D6 (0.50) SIGMAR1TSHRKMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7119091-B2 Triazaspiro[5.5]undecane derivatives and pharmaceutical compositions comprising thereof, as an active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2006-10-10 US disclosed